The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
The primary goal of the collaboration is joint research into trending and next-generation molecules
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion
It's a development that marks a potential breakthrough for people living with the rare and debilitating disease Duchenne muscular dystrophy (DMD)
Subscribe To Our Newsletter & Stay Updated
